Duke Capital Limited, a leading provider of hybrid capital solutions for SME business owners in Europe and North America, has announced the approval of 6,226,000 conditional rights to acquire ordinary shares of no par value ("PSAs") under the Company's Long-Term Incentive Plan ("LTIP"). These PSAs will vest after a period of three years and are subject to various performance conditions outlined in the Company's admission document. The PSAs will be subject to performance conditions, with 50% based on growth in total shareholder return ("TSR") and 50% on growth in total cash available for distribution per share ("TCAD per Share").
Additionally, a total of 1,317,503 PSAs, previously granted under the Company's LTIP in relation to the financial year ended 31 March 2021, have vested, representing 62.5% of the PSAs granted at that time. Following these transactions, certain Directors/PDMRs have a total interest in ordinary shares, with Neil Johnson holding 7,423,236 shares and Charlie Cannon Brookes holding 10,264,688 shares.
In order to maintain an appropriate level of headroom within the Company's Employee Benefit Trust (EBT), the Company has issued 2,872,403 new ordinary shares into the Duke Royalty EBT. Following the transfer of these shares to LTIP beneficiaries, the Company will have 424,361,137 ordinary shares in issue admitted to trading on AIM, of which 7,617,600 will be held by the EBT.
For further information, interested parties can visit the company's website or contact Duke Capital Limited directly. The company's Nominated Adviser and Joint Broker is Cavendish Capital Markets Limited, and Canaccord Genuity Limited serves as the Joint Broker. Notifications of dealings by PDMRs have also been provided in the announcement.